NCT03680677
Recruiting
N/A
Prospective Analysis of Frailty Phenotype Assessments to Optimize Treatment Strategies for Older Patients With Hematologic Malignancies
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Leukemia, Acute
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Enrollment
- 20
- Locations
- 1
- Primary Endpoint
- Non-Relapse Mortality (NRM) in Frail, Pre-Frail, and Non-Frail patients
- Status
- Recruiting
- Last Updated
- 9 months ago
Overview
Brief Summary
The purpose of this research study is to determine if frailty assessments can be used to predict how well patients aged 60 years and older will do after chemotherapy, CAR T-cell therapy, or allogeneic stem cell transplant.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Non-Relapse Mortality (NRM) in Frail, Pre-Frail, and Non-Frail patients
Time Frame: 1-month
NRM will be defined as death without evidence of disease progression or relapse.
Secondary Outcomes
- NRM by Intensity of Treatment(1-month and 6-month)
Study Sites (1)
Loading locations...
Similar Trials
Active, Not Recruiting
N/A
Validating the Use of Frailty Measurements to Predict Care & Quality of LifeChronic Obstructive Pulmonary DiseaseNCT06325241Ottawa Hospital Research Institute123
Unknown
N/A
Comprehensive Validation of Frailty Assessment Tools in Older Adults in Different Clinical and Social SettingsSyndromeNCT02637518Hospital Universitario Getafe1,940
Completed
N/A
Use of Device Data to Predict Frailty in IndividualsAge ProblemMoralityArrhythmias, CardiacNCT03079726University of Colorado, Denver50
Completed
N/A
Clinical Frailty Assessment and Postoperative Adverse Outcomes and Quality of Life in Elderly PatientsPerioperative ComplicationsNCT05387850Chinese PLA General Hospital12,000
Recruiting
N/A
Comparison of Frailty Screening Performance and Predictive Validity of Adverse Health Outcomes in Breast Cancer Patients Using Frailty Screening ToolsFrailty SyndromeNCT06467149Ju Qiu500